Improved clinical outcome in a randomized phase II study of anti-PD-1 camrelizumab plus decitabine in relapsed/refractory Hodgkin lymphoma - Concepedia

Concepedia

Publication | Open Access

Improved clinical outcome in a randomized phase II study of anti-PD-1 camrelizumab plus decitabine in relapsed/refractory Hodgkin lymphoma

DOI Full Paper Access

63

Citations

29

References

2021

Year

Yang Liu, Chunmeng Wang, Xiang Li, Liang Dong, Qingming Yang, Meixia Chen, Fengxia Shi, Malcolm V. Brock, Miao Liu, Qian Mei,

Journal for ImmunoTherapy of Cancer

Abstract

NCT02961101 and NCT03250962.

References

	Year	Citations

Page 1